Skip to Main Content
Try STAT+ TODAY
Trending:
Biotech
STAT+
Health
First Opinion
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Business
STAT+

Can we treat disease with electrical pulses? Investors are intrigued

By Charles Piller Sept. 12, 2017

Reprints
SetPoint bioelectronic device
SetPoint plans further tests of its bioelectronic device. SetPoint

OAKLAND, Calif. — Electricity is still hot.

The much-hyped field of “electroceuticals” — which involves zapping nerves with tiny electrical pulses to treat disease — got another injection of funds late last month with a $30 million investment round for startup SetPoint Medical.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Charles Piller

Contributing Writer

Charles is a California-based project and investigative reporter.

Tags

FDA pulls Evusheld authorization as coronavirus evolution quashes another…
FDA pulls Evusheld authorization as coronavirus evolution quashes another therapy
Live blog: Tracking the meeting of the FDA advisory…
Live blog: Tracking the meeting of the FDA advisory panel on Covid vaccines
It’s time to retire ‘poor historian’ from clinicians’ vocabularies
It’s time to retire ‘poor historian’ from clinicians’ vocabularies
HHS’ Becerra on enrolling in Medicare, annual Covid vaccines,…
HHS’ Becerra on enrolling in Medicare, annual Covid vaccines, and seniors’ mental health
Warren urges the FTC to scrutinize two pharma mergers…
Warren urges the FTC to scrutinize two pharma mergers over “anti-competitive” practices
Pharmalittle: Strange bedfellows lobby for Medicare coverage of obesity…
Pharmalittle: Strange bedfellows lobby for Medicare coverage of obesity drugs; FDA working with WHO to probe…

Recommended Stories